YanAn Bicon Pharmaceutical Listed Company
Simbol: 002411.SZ
SHZ
0.62
CNYPrețul de piață astăzi
-0.5881
Raportul P/E
-0.0152
Raportul PEG
950.01M
MRK Cap
- 0.00%
Randament DIV
YanAn Bicon Pharmaceutical Listed Company (002411-SZ) Situații financiare
Bilanț
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 3267.61 | 950.2 | 842.6 | 710.4 | |||||||||||||||||
balance-sheet.row.short-term-investments | 194.74 | 73.1 | -240.1 | -216.7 | |||||||||||||||||
balance-sheet.row.net-receivables | 19813.77 | 4260.2 | 5748.3 | 5945.8 | |||||||||||||||||
balance-sheet.row.inventory | 3740.51 | 788.2 | 978.6 | 763.9 | |||||||||||||||||
balance-sheet.row.other-current-assets | 319.4 | 76.3 | 106.9 | 85.1 | |||||||||||||||||
balance-sheet.row.total-current-assets | 27141.29 | 6074.9 | 7676.5 | 7505.3 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 18876.13 | 2910 | 6651.1 | 8593.4 | |||||||||||||||||
balance-sheet.row.goodwill | 6512.07 | 1614.7 | 1641.3 | 1641.3 | |||||||||||||||||
balance-sheet.row.intangible-assets | 2412.53 | 531 | 670.9 | 774.6 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 8924.59 | 2145.8 | 2312.2 | 2416 | |||||||||||||||||
balance-sheet.row.long-term-investments | -30.09 | -15 | 288.5 | 261.6 | |||||||||||||||||
balance-sheet.row.tax-assets | 2272.59 | 984.9 | 151.9 | 171.9 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 9353.57 | 2761.1 | 1643.1 | 259.3 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 39396.78 | 8786.7 | 11046.8 | 11702.2 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 66538.08 | 14861.6 | 18723.3 | 19207.4 | |||||||||||||||||
balance-sheet.row.account-payables | 7878.36 | 1892 | 2036.3 | 2142.7 | |||||||||||||||||
balance-sheet.row.short-term-debt | 10572.87 | 1553 | 4617.7 | 4005.3 | |||||||||||||||||
balance-sheet.row.tax-payables | 3673.99 | 1062.4 | 1031.9 | 779 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 2554.55 | 231.9 | 283.2 | 1084.8 | |||||||||||||||||
Deferred Revenue Non Current | 504.79 | 126.1 | 132.9 | 139.2 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 58 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 14694.58 | 4597 | 20.2 | 46.3 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 4284.47 | 656.7 | 727.6 | 1285.9 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 55.85 | 12.6 | 29.9 | 19.3 | |||||||||||||||||
balance-sheet.row.total-liab | 37430.28 | 8698.7 | 10650.4 | 10276.4 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 7113.22 | 1778.3 | 1778.3 | 1778.3 | |||||||||||||||||
balance-sheet.row.retained-earnings | -1660.9 | -1317.7 | 247.4 | 1204.5 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 21853.18 | 5312.8 | 5601.3 | 5522.6 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 27305.5 | 5773.3 | 7627 | 8505.5 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 66538.08 | 14861.6 | 18723.3 | 19207.4 | |||||||||||||||||
balance-sheet.row.minority-interest | 1802.3 | 389.5 | 446 | 425.6 | |||||||||||||||||
balance-sheet.row.total-equity | 29107.8 | 6162.9 | 8073 | 8931 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 66538.08 | - | - | - | |||||||||||||||||
Total Investments | 213.13 | 58.1 | 48.4 | 44.9 | |||||||||||||||||
balance-sheet.row.total-debt | 13127.42 | 1784.9 | 4900.9 | 5090.1 | |||||||||||||||||
balance-sheet.row.net-debt | 10006.06 | 907.8 | 4058.2 | 4379.7 |
Situația fluxurilor de numerar
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -1560.63 | -1054.7 | -659.7 | -1054.3 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 350.1 | 403.3 | 338.9 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 2112.3 | -732.8 | -1104.2 | |||||||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.inventory | 0 | -8.4 | -212.8 | -1.6 | |||||||||||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.other-working-capital | 0 | 2120.8 | -520 | -1102.6 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 1517.5 | 1590.6 | 1454.5 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -1560.63 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -1498.5 | -1452.8 | -281.1 | -143.7 | |||||||||||||||||
cash-flows.row.acquisitions-net | 1335.58 | 1335.6 | 0 | 0.1 | |||||||||||||||||
cash-flows.row.purchases-of-investments | -25.7 | -25.6 | 205.5 | -0.3 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0.01 | 996 | 3.8 | 0.7 | |||||||||||||||||
cash-flows.row.other-investing-activites | 985.62 | -10.3 | 132.8 | 1194.8 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 797.01 | 842.8 | 60.9 | 1051.7 | |||||||||||||||||
cash-flows.row.debt-repayment | -3769.74 | -3339 | -647.6 | -3023.1 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.dividends-paid | -2054.05 | -2021.4 | -200.1 | -431.2 | |||||||||||||||||
cash-flows.row.other-financing-activites | 2695.35 | 2222.5 | 460.1 | 2738.8 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -3128.44 | -3137.9 | -387.6 | -715.5 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 23.75 | 23.7 | -1 | -0.4 | |||||||||||||||||
cash-flows.row.net-change-in-cash | -227.08 | 653.9 | 273.8 | -29.3 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 2538.32 | 1154.2 | 500.7 | 226.8 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 2765.4 | 500.3 | 226.8 | 256.1 | |||||||||||||||||
cash-flows.row.operating-cash-flow | -1560.63 | 2925.3 | 601.4 | -365 | |||||||||||||||||
cash-flows.row.capital-expenditure | -1498.5 | -1452.8 | -281.1 | -143.7 | |||||||||||||||||
cash-flows.row.free-cash-flow | -3059.13 | 1472.4 | 320.3 | -508.8 |
Rândul din contul de profit și pierdere
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 7057.74 | 8106.3 | 7663.2 | 6939.5 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 5817.12 | 6075.1 | 5311.9 | 5613.1 | |||||||||||||||||
income-statement-row.row.gross-profit | 1240.61 | 2031.2 | 2351.2 | 1326.4 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 127.63 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 34.99 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 290.11 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | 1153.16 | 1157.5 | 325.1 | 306.9 | |||||||||||||||||
income-statement-row.row.operating-expenses | 1605.89 | 1719.5 | 856.8 | 946.7 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 7423.02 | 7794.6 | 6168.7 | 6559.8 | |||||||||||||||||
income-statement-row.row.interest-income | -4.19 | -6 | 16 | 20.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 201.51 | 283.7 | 357.9 | 1135.6 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 290.11 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -518.6 | -2001.5 | -1587.9 | -2048.9 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | 1153.16 | 1157.5 | 325.1 | 306.9 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -518.6 | -2001.5 | -1587.9 | -2048.9 | |||||||||||||||||
income-statement-row.row.interest-expense | 201.51 | 283.7 | 357.9 | 1135.6 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 1448.87 | 350.1 | 403.3 | 338.9 | |||||||||||||||||
income-statement-row.row.ebitda-caps | -271.28 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | -1720.15 | 342.9 | 1219.9 | 930.6 | |||||||||||||||||
income-statement-row.row.income-before-tax | -2238.75 | -1658.6 | -368 | -1118.3 | |||||||||||||||||
income-statement-row.row.income-tax-expense | -692.52 | -603.9 | 291.7 | -45.5 | |||||||||||||||||
income-statement-row.row.net-income | -1560.63 | -1054.7 | -659.7 | -1072.8 |
Întrebări frecvente
Ce este YanAn Bicon Pharmaceutical Listed Company (002411.SZ) totalul activelor?
YanAn Bicon Pharmaceutical Listed Company (002411.SZ) activele totale sunt 14861598713.000.
Care este venitul anual al întreprinderii?
Venitul anual este 3146759640.000.
Care este marja de profit a întreprinderii?
Marja de profit a firmei este 0.155.
Care este fluxul de numerar liber al întreprinderii?
Fluxul de numerar liber este -1.981.
Care este marja de profit net a întreprinderii?
Marja profitului net este -0.303.
Care este venitul total al întreprinderii?
Venitul total este -0.342.
Care este YanAn Bicon Pharmaceutical Listed Company (002411.SZ) profitul net (venitul net)?
Profitul net (venitul net) este -1054699022.740.
Care este datoria totală a firmei?
Datoria totală este 1784935683.000.
Care este numărul cheltuielilor de exploatare?
Cheltuielile de exploatare sunt 1719493052.000.
Care este cifra de numerar a firmei?
Numerarul întreprinderii este 489995625.000.